Martin Munte Email and Phone Number
Martin Munte work email
- Valid
- Valid
Martin Munte personal email
Martin Munte phone numbers
Experienced Leader in Pharma/Biotech in Europe with special focus on the Big 5 markets, Country General Management in mid-sized markets and Pharma association leadership. High impact negotiator with key stakeholders, skilled C-suite communicator & presenter. Clear definer & executor of Business Development strategies and go to market models. Successful P&L track record, proven coaching & talent management. High organizational, change management skills and capabilities with impactful implementation of key strategies. Commercial, Sales & Marketing, Market Access, Pricing, Business Development and Regulatory Affairs senior leadership.
Vaccentis
View-
CeoVaccentis Jul 2022 - PresentZürich , Switzerland , ChVaccentis AG is a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines to improve patients’ chances of recovery from chronic and malignant diseases. Vaccentis’ product pipeline includes VCC-001, Autologous Serum Eye Drops (ASAT), Individual Immunotherapy, and Urexent®. VCC-001 is in clinical development to treat non-metastatic renal cell carcinomas; prepared from the patients’ tumors, it stimulates the immune system to attack tumor cells and reduces the risk of recurrence and metastases. ASAT is an efficient treatment of dry eye diseases prepared from the patient’s blood. Research suggests it may be more effective and better tolerated than traditional tear replacement products.
-
Senior Executive Consultant & AdvisorLife Sciences (Pharma + Biotech + Medtech) Sep 2021 - Jun 2022SCOPE OF SERVICES:STRATEGIC ASSESSMENTS AND PLANS• Macroeconomic analysis - health care environment• Strategy and portfolio assessment • Scenario analysis and impact assessments• Go-to-market launch models • Growth strategy plans – Innovative and BiosimilarsORGANIZATIONAL EXCELLENCE & EFFECTIVENESS• Headquarter and Affiliates: Marketing & Sales, Government Affairs, Policy, Access, Regulatory and Pricing o Responsibilities, communication and collaboration o Integrative planning and execution o Commercial excellence: Digital innovation & multi channel • Governance for successful product launches & defencePERFORMANCE MANAGEMENT - PROGRAMM AND INTERIM MANAGEMENT• Government Affairs & External Engagement plans• Business plan execution (Milestone/ KPI tracking)• Business case/business development support• Dedicated project management• P&L (Turnaround) managementORGANIZATIONAL CHANGE JOURNEYS • Culture development, milestone tracking, talent retention ESTABLISHMENT AND MANAGEMENT OF PARTNERSHIPS• Pharma/Biotech: KOLs, Payors, Government stakeholders -
External Access Engagement Lead EuropeAmgen Jun 2019 - Sep 2021Thousand Oaks, Ca, UsLeading all European Policy, Government Affairs and Professional Associations efforts for EU-Stakeholder and Business management to achieve optimal Access• Implementing key Policy activities and changes to shape the Access Environment and to enable optimal Access for the Amgen Brand, Biosimilar and Pipeline products • Provide strategic and tactical advice based on key Policy Priorities for affiliates • Develop/ collect and provide policy material to regional brand teams and affiliates • Lead or support related activities/ projects (as part of a cross-functional team) • Identification of EU policy trends and priorities • Set up/ orchestrate activities to shape future policies and budgets on the EU level together with industry organizations and individually in collaboration with affiliates -
General ManagerAmgen Jul 2009 - Jun 2019Thousand Oaks, Ca, Us115 Employees, 120 $M sales • Managing Director with full P&L responsibility and Executive Director under trade law • All product launches successfully reimbursed with optimal patient access from 2009 to 2019 • Sales doubled and profit tripled in period • New indications launched: Bone, Cardio, Biosimilars with MS leadership
-
General Manager Amgen SlovakiaAmgen Oct 2017 - Sep 2018Thousand Oaks, Ca, Us45 employees, 45 $M sales • Successful reimbursement and launch for innovative products• Highest MS for Bone in Europe
-
General Manager Amgen İlaç, IstanbulAmgen Oct 2013 - Oct 2014Thousand Oaks, Ca, Us60 Amgen + 1400 MN employees • Sales turnaround from 20 $M to 60 $M • Built up of Amgen Oncology business, fostered the MN integration, reintegration of GCSF business from Roche and launch of innovative Amgen products • Led Amgen Turkey to its first year of profit (from -12 $M to +20 $M)
-
Marketing & Sales Director Specialty CareAstrazeneca Jul 2007 - Jun 2009Cambridge, Cambridgeshire, Gb• Member of the Leadership team, Executive Secretary • Direct P&L Responsibility for Oncology and CNS Business Units -
Market Access, Regulatory & Business Development DirectorAstrazeneca Sep 2004 - Jun 2008Cambridge, Cambridgeshire, Gb• Member of the Leadership team, Executive Secretary • Responsible for Market Access, Regulatory and Business Development & Pricing
-
Marketing Manager Primary CareAstrazeneca Sep 2002 - Aug 2004Cambridge, Cambridgeshire, Gb• Head of Marketing Cardiovascular, Gastrointestinal, Respiratory and Hospital • Leadership, Coaching and Development of 17 Managers within the Marketing Primary Care Department
-
Sales ManagerRoche May 2001 - Aug 2002Switzerland 🇨🇭 , Ch• Cardio/Osteoporosis Region East/South • Leadership, Coaching and Development of 9 Field Representatives -
Produkt ManagerRoche Mar 2000 - Apr 2001Switzerland 🇨🇭 , Ch• Responsible for the Launch of the neuraminidase inhibitor Tamiflu for Influenza, for Infection and Anaesthesia
-
Product Spezialist, Product Manager Und Team LeaderAstrazeneca May 1997 - Feb 2000Cambridge, Cambridgeshire, Gb• Project Manager for the new AstraZeneca Sales Force Organization • Coordinator of the Focus Merger Project • Member of the Marketing & Sales Task Force • Member of the site selection team 05/1997 - 06/1999 Field Product Specialist Hospital • Product Management and Field Representative at the University Hospital Graz
Martin Munte Skills
Martin Munte Education Details
-
Wu (Vienna University Of Economics And Business)Handelswissenschaften
Frequently Asked Questions about Martin Munte
What company does Martin Munte work for?
Martin Munte works for Vaccentis
What is Martin Munte's role at the current company?
Martin Munte's current role is Pharma & Biotech CEO | Expert in General Management | Leadership | Implementation | Business Operations | +25 Years of Experience.
What is Martin Munte's email address?
Martin Munte's email address is ma****@****gen.com
What is Martin Munte's direct phone number?
Martin Munte's direct phone number is .805.447*****
What schools did Martin Munte attend?
Martin Munte attended Wu (Vienna University Of Economics And Business).
What skills is Martin Munte known for?
Martin Munte has skills like Biotechnologie, Pharmaindustrie, Management, Arzneimittelverkauf, Marktzugang, Cross Functional Team Leadership, Biotechnology, Pharmaceutical Industry, Pharmaceutical Sales, Onkologie, Market Access, Marketingstrategie.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial